Overview EryDex Pharmacokinetics in Healthy Volunteers Status: Completed Trial end date: 2013-10-01 Target enrollment: Participant gender: Summary To compare the pharmacokinetic properties of two different doses of EryDex (dexamethasone sodium phosphate encapsulated in erythrocytes) given as a single infusion in healthy volunteers, based on plasma concentrations of dexamethasone. Phase: Phase 1 Details Lead Sponsor: ErydelTreatments: BB 1101DexamethasoneDexamethasone 21-phosphateDexamethasone acetate